Is grateful to be blessed with good fortune.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Granted Canadian patent!
Cannabix Technologies Granted Cannabis Drug Detection Device Canadian Patent, Delivers THCBA to US Clinic
Cannabix is developing Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safety
Vancouver, British Columbia -- July 6, 2021 -- InvestorsHub NewsWire -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the "Company" or "Cannabix") developer of the Cannabix Marijuana Breathalyzer devices for law enforcement and the workplace, announces that the Canadian Intellectual Property Office (CIPO) has granted patent No. 2887841 entitled, "Cannabis Drug Detection Device". The Company has been pursuing this original patent application since its filing on April 16, 2015. Cannabix Technologies is on the forefront in research and development to create point-of-care breath testing technologies for the detection of ?9-tetrahydrocannabinol ("THC") - the psychoactive component of marijuana that causes impairment.
"Similar to our USPTO patent, the intellectual property protection this THC detection patent covers, gives Cannabix a broad foundation to build upon in view of the formidable insights and technical advancements made in the field of molecular gas analysis at atmospheric pressure that we have developed since this patent was initially filed in 2015. This patent is a useful plank in our IP protection strategy" said Dr. Raj Attariwala.
The Company also reports that in June it delivered its THC Breath Analyzer ("THCBA") to a clinic in the Northwestern, U.S. for beta testing. The collaborating clinic has a robust drug testing operation and is one of the top drug testing providers to employers within its respective state. Beta-testing of the THCBA prototype is focused on improving user and administrator experience, identifying cross-reactivity of other substances within a semi-controlled study population and to further train the device's machine learning database and sensitivity profile. The THCBA is a drug screening device for employers and other markets who are seeking a way to quickly, easily and non-invasively test for recent use of THC.
"In the last several months we have seen the states of Oregon, New Jersey, New York and Arizona legalize recreational use of marijuana and several other states like Virginia, New Mexico, Montana and Connecticut have taken steps to either legalize or decriminalize cannabis possession in some way. This has led to recent reports from AAA and IIHS outlining the impact of driving performance under the influence of cannabis. Furthermore, employers are re-examining their drug testing policies, procedures and tools. There is a massive sea-change happening in the U.S. related to cannabis use and Cannabix Technologies is at the forefront of developing the tools to aid public safety and create more relevant and fairer cannabis testing technology", stated CEO, Rav Mlait.
About Cannabix Technologies Inc.
Cannabix Technologies Inc. is a developer of marijuana breathalyzer technologies for law enforcement and the workplace. Cannabix is working to develop drug-screening devices that will detect THC - the psychoactive component of marijuana that causes impairment using breath samples. Breath testing for THC would allow employers and law enforcement to identify recent marijuana use that better aligns with impairment.
We seek Safe Harbor.
On behalf of the Board of Directors
"Rav Mlait"
CEO
Cannabix Technologies Inc
Amazing
Love it when a plan comes together
Don't invest money that you need to live, this IS financial advice.
Yup, fuck cancer. $RGBP
It'll move when you BUY, not financial advice.. I just loaded 6 million shares throughout the day and am out of dry powder. When this hits $10.00 everyone will be sad they didn't load up at 1.5 pennies.
Bought another 6 million shares today, LFG!
Bargain prices. Just a matter of time.
Audit will bring RGBP current soon
RGBP Long and strong.
Bounced off April 15th engulfing bull candle low
Morning! This month will be huge for RGBP!
I cant tell if you're serious or just f'ing around.
MONDAY STARTS THE NEW MONTH, will be huge for RGBP imo, get in now. The Monthly chart is extremely bullish. HODL, don't flip and get left in the dust with sellers remorse, history shows that this can go to $1.00 on the monthly charts when inevitable catalyst 8ks regarding the financial current status updates and future profitability 8ks are updated.
Next week starts the new monthly candle on the chart, Next month will be huge for RGBP imo, get in now. The Monthly chart is extremely bullish. HODL, don't flip and get left in the dust with sellers remorse.Next week starts the new monthly candle on the chart, Next month will be huge for RGBP imo, get in now. The Monthly chart is extremely bullish. HODL, don't flip and get left in the dust with sellers remorse, history shows that this can go to $1.00 on the monthly charts when inevitable catalyst 8ks regarding financial current status updates and future profitability 8ks are updated.
The volume and momentum on the big interval frames, where on the chart the candlesticks are 1 month and 3 month intervals is what got me here. This stock's momentum could be in an uptrend for 3months to a year easy. Charts have fractal elements to them, the bigger the chart interval and the bigger the buy signal, the stronger and longer the move. It took me 20 years to understand that.
People need to realize where the demand is. Strike the iron while it's hot!
MRNA, siRNA treatments are a quantum leap in medicine! The research will never stop. The lab hours and resources RGBP utilized and the IP they have are extremely undervalued here.
The shares left in the float are getting eaten alive, it's only a short matter of time before Koos releases more eye popping 8-ks. This thing is going to fly!!!
Seriously though, one of the most important discoveries in health care to date Is being utilised to defeat one of the most devastating viruses in the history of mankind. How does a person not hold this stock like the life changer that it is?
I like makers mark!
It's the MRNA era! Big pharma wants all the IP it can get!
Less shares available every day, soon people will be paying higher and higher prices.
When this is .25 In a couple weeks all the sellers are gonna cry.
Me too, i'm betting ELi Lilly is still in the picture somehow...
Sid, good DD you posted about ex Eli Lilly exec Jean-Pierre Millon?
https://www.linkedin.com/in/jp-millon-5353506/
I'm sure David Koos could get him on the phone anytime, they had an extensive agreement in this old 10k for JP millon to look for buyers that i'm sure could be easily renewed.
https://www.otcmarkets.com/filing/html?id=12464180&guid=9TnoUpwMD3q4I3h
"...We have also established a Business Advisory Board. Members of the Business Advisory Board (“BAB”) include:
Jean Pierre Millon
On October 16, 2017 Mr. Millon agreed to serve as Chairman of the BAB pursuant to an agreement by and between Millon and the Company (“Millon BAB Agreement”).
Mr. Millon currently serves on the Board of Directors of CVS Health. Mr. Millon previously served as President and Chief Executive Officer of PCS Health Systems , Inc. from June 1996 until his retirement in September 2000. Mr. Millon also previously served in an executive capacity at Eli Lilly and Company.
The term of the Millon BAB Agreement shall be from October 9, 2017 to October 9, 2020.
The Millon BAB Agreement requires Millon to
(a) meet with the Company upon written request, at dates and times mutually agreeable to Hopkins and the Company, to discuss any matter involving the Company or its subsidiaries
(b) utilize his best efforts to :
Identify and introduce to the Company persons not previously known to the Company to serve as members of the Company’s Business Advisory Board (“Advisory Candidates”).
Identify and introduce to the Company potential purchasers of the Company’s securities, such purchasers not previously known to the Company (“Buyers”)
As consideration for agreeing to serve, Millon is to receive a total of 6,000,000 of the Company’s Series M Preferred shares (“Millon BAB Shares”).
4,000,000 of the BAB Shares were issued to Millon on November 1, 2017. An additional 1,000,000 of the BAB Shares are to be issued on the second anniversary of the Millon BAB Agreement and an additional 1,000,000 of the Millon BAB Shares are to be issued on the third anniversary of the Millon BAB Agreement.
Millon may convert his Millon BAB Shares into an equivalent number of the common shares of the Company upon the sooner of:
a) the execution of a licensing agreement for the Company’s NR2F6 intellectual property, or,
b) upon the third anniversary of the Millon BAB Agreement..
In the event that a candidate identified and introduced by Millon to the Company serves as a member of the BAB, Millon shall receive, ten business days subsequent to the completion of 12 months service by the candidate as a member of the BAB a referral fee equal to 5% (paid to Millon in Series M Preferred shares of the Company) of the shares of the Series M Preferred shares of the Company issued to the referred candidate.
In the event of a purchase of securities by one or more Buyers, such Buyers not previously known to the Company and identified and introduced by Millon to the Company, Millon shall receive a referral fee equal to 5% (paid to Millon in Series M Preferred shares of the Company) of the shares of common stock of the Company purchased by the Buyer...
I used to work in cardiac electrophysiology, that leadless pacemaker through the femoral vein into the right side of the heart is simply amazing. Godspeed to your recovery! it'll be very quick:)
Thats because after 15 billion shares traded this month, investors are owning the float finally and there's less shares out there. That's a very bullish observation after the huge volume spike we witnessed this month.
He's in an audit, he can only disclose limited info, that 8k was HUGE today. Showing shareholders a little of his killer hand and keeping institutional big buyers in check. Koos worked in venture capitalism and finance, we're lucky he's the ceo again imo. This is what he does, he's a deal maker and he's good at it.
I hear you, 8k today said nonconvertible gives koos some credit worthiness imo, he can't sell those, shows he isn't selling. He would have to sell in a blind trust if he did sell, and he's not gonna do that during an audit.
15 billion shares traded, churned the O/S 4x over this month, does it really matter? RGBP is a BULL BEAST
The current audit will answer all of these questions, they're going to be current soon.
Likely just past convertible debt adjustments brought forward by the audit, the buying pressure churned the A/S nearly 4x over in April alone with 15 billion shares traded.
Broke up out of the triangle on the Daily chart.
Logical, yea for sure.
Yes, he's definitely talking through the 8k to big investors, completely agreee.
Nonconvertible! Shows Koos is committed and not diluting anything.
A noncallable, nonconvertible preferred stock is a nonconvertible preferred stock which does not give the issuer the right to call in or redeem the preferred stock at a preset price after a predetermined date.
https://www.otcmarkets.com/filing/html?id=14894907&guid=5-RnUHnuV5FPTth
Thanks! Huge 8k imo, big investors, koos maintains voting rights!
I agree, the monthly and weekly chart are still very bullish imo. These daily fluctuations are opportunities to get in.
5 MILLION ON THE BID JUST NOW
FLOAT IS GETTING OWNED SO VOLUME IS LOWER, THERE'S LESS SHARES TO TRADE BECAUSE THERE'S LESS PEOPLE WHO WANT TO SELL THEIR SHARES AT THESE LEVELS, MEANING INVESTORS ARE NOW HOLDING THE FLOAT. ASKS ARE THIN.